Особености в протичането, диагностиката и лечението на медикаментозно индуцирания ангиоедем и на ангиоедема при жени
Keywords:
медикаментозно индуциран ангиоедем, наследствен ангиоедем при жени
Abstract
През последните години значително нарасна броят на прилаганите лекарства и съответно на тези, които отключват директно или непряко са свързани с развитието на ангиоедем. От докладваните до момента случаи ще разгледаме тези, които са свързани с употребата на нестероидни противовъзпалителни средства, инхибиторите на ангиотензин конвертиращия ензим, ангиотензин 2-рецепторни агонисти, антибиотици и естрогенови препарати.
При жените с наследствен ангиоедем заболяването се отличава с по-тежко протичане, което според някои автори се дължи на влошаване от периодите на хормонални промени в организма – пубертет, бременност, менструация. Според други, това влошаване се наблюдава и при добавяне на женски полови хормони в рамките на хормонозаместителна терапия или като метод за контрацепция.
References
Дерменджиев С, Пенчев Б, Делева П и съавт. Уртикария и ангиоедем при професионално експонирани на латекс лица – клиничен случай. Алергии Хиперсензитивност Астма 2013, 10 (1):53-60.
Sanchez-Borges M, Gonzalez-Aveledo LA. Angiotensinconverting enzyme inhibitors and angioedema. Allergy Asthma Immunol Res 2010;2:195-8.
Bork K, Fischer B, Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med 2003;114: 294-8.
Дерменджиев С. Тежка алергична патология при професионална експозиция на материали от военната промишленост. Алергии Хиперсензитивност Астма 2014, 11 (1):76-82.
Дерменджиев С, Делева П. Алергични реакции от субстанции с неизвестен физико-химичен състав. Bulgarian medicine 2013, 4: 46- 50.
Bouillet L, Longhurst H, Boccon-Gibod I et al. Disease expression in women with hereditary angioedema (PREHAEAT). Am J Obstet Gynecol 2008;199(484):e1-4.
Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999 Jun;57(6):1005-32.
Дерменджиев С, Делева П, Пенчев Б. Наследственият ангиоедем – сериозен проблем за здравето при деца и млади пациенти. Medinfo 2014; 8 :56-59.
Chi C, Kulkarni A, Lee CA et al. The obstetric experience of women with factor XI deficiency. Acta Obstet Gynecol Scand 2009;88:1095-100.
Дерменджиев С, Симеонова Р. Рядко срещани алергични прояви при козметични манипулации. В: Трета национална конференция за редки болести – конферентен сборник, 2013: 125-126.
Manikkam M, Crespi EJ, Doop DD et al. Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology 2004;145:790-8.
Дерменджиев С. Кожно-лигавични алергични прояви при селскостопанските работници. Bulgarian medicine 2014, 3: 32- 36.
Sathishkumar K, Elkins R, Yallampali U et al. Elevated androgens levels during pregnancy impair fetal growth due to placental insufficiency and programs for adult hypertension in rats. Biol Reprod 2009;81:250.
Дерменджиев С. Алергия и хомеопатични лекарствени продукти – парадокс, възможен риск или нещо друго: клиничен случай. Алергии Хиперсензитивност Астма 2011, 8(1):40-54.
Czaller I, Visy B, Csuka D et al. The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey. Eur J Obstet Gynecol Reprod Biol 2010;152:44-9.
Дерменджиев С. Книжният прах – рисков фактор за сенсибилизация при професионално експонирани лица. В: Трета национална конференция за редки болести – конферентен сборник, 2013: 118-120.
Hardy F, Ngwingtin L, Bazin C, et al. Hereditary angioneurotic edema and pregnancy. J Gynecol Obstet Biol Reprod (Paris) 1990;19:65-8.
Firazyr (icatibant acetate). Berlin (Germany): Jerini AG; 2009.Kalbitor (ecallantide). Cambridge (MA): Dyax Corp; 2009.
Kalbitor (ecallantide). Cambridge (MA): Dyax Corp; 2009.
Мурджева М, Спасова М, Бошева М и съавт. Първични имунни дефицити – експертна дейност за диагностика и лечение в УМБАЛ „ Свети Георги“. В: Четвърта национална конференция за редки болести и лекарства сираци – конферентен сборник, 2013: 78.
Tranexamic acid (Lysteda) for treatment of menorrhagia. Med Lett Drugs Ther 2010;52:54-5.
Visy B, Fust G, Varga L et al. Sex hormones in hereditary angioneurotic oedema. Clin Endocrinol (Oxf) 2004;60:508 15.
Cyklokapron (Pharmacia). In: Krogh CME, editor. Compendium of pharmaceutical and specialties. 28th ed. Ottawa: Canadian Pharmaceutical Association; 1993: 311-2.
Campbell SJ, Mackie IJ, Robinson GE, et al. Contact factor mediated fibrinolysis is increased by the combined oral contraceptive pill. Br J Obstet Gynaecol 1993;100:79-84.
Pelissier C, Blacker C, Feinstein MC et al. Antiovulatory action of chlormadinone acetate. Contracept Fertil Sex (Paris) 1994;22:37-40.
Cimbollek S, Gonzalez-Quevedo T, Diaz M. To become or not become pregnant with hereditary angioedema. The 5th C1-INH DeficiencyWorkshop; May 31-June 2, 2007; Budapest, Hungary. Abstract book: 30.
McGlinchey PG, McCluskey DR. Hereditary angioedema precipitated by estrogen replacement therapy in a menopausal woman. Am J Med Sci 2000;320:212-3.
Madsen JS, Kristensen SR, Gram J et al. Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women. J Thromb Haemost 2003;1:1984-91.
Nelson HD. Menopause. Lancet 2008;371:760-70.
Fechner S, Husen B, Thole H et al. Expression and regulation of estrogen-converting enzymes in ectopic human endometrial tissue. Fertil Steril 2007;88(suppl 4):1029-38.
Rousset-Jablonski C, Thalabard JC, Gompel A. Tamoxifen contraindicated in women with hereditary angioedema? Ann Oncol 2009;20:1281-2.
Bellver J, Pellicer A. Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome. Fertil Steril 2009;92:1803-10.
Humaidan P, Quartarolo J, Papanikolaou EG. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril 2010;94:389-400.
Caballero Т et al. Consensus Statement on the Diagnosis, Management, and Treatment of Angioedema Mediated by Bradykinin. Part II. Treatment, Follow-up, and Special Situations. J Investig Allergol Clin Immunol 2011; 21(6): 422-441.
Wilkin JK, Hammond JJ, Kirkendall WM. The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation. Arch Dermatol1980;116:902–5.
Slater EE , Merrill DD, Guess HA et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 1988;260:967–70.
Sigler C, Annis K, Cooper K, Haber H, Van deCarr S. Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor. Arch Dermatol. 1997 Aug;133(8):972-5.
Banerji A, Clark S, Blanda M, et al. Multicenter study of patients with angiotensin-converting enzyme inhibitorinduced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 2008;100:327–32.
Blais C Jr, Rouleau JL, Brown NJ et al. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin converting enzyme inhibitor-associated angioedema. Immunopharmacology 1999;43:293-302.
Duan QL, Nikpoor B, Dube MP et al. A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am J Hum Genet 2005;77:617-26.
Sprinkle TJ, Stone AA, Venema RC et al. Assignment of the membrane-bound human aminopeptidase P gene (XPNPEP2) to chromosome Xq25. Genomics 1998;50:114-6.
Bas M, Hoffmann TK, Kojda G. Evaluation and management of angioedema of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2006;14:170-5.
ONTARGET Investigators, Yusuf S, Teo KK et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008;358:1547-59.
Malde B, Regalado J, Greenberger PA. Investigation of angioedema associated with the use of angiotensinconverting enzyme inhibitors and angiotensin receptor blockers. Ann Allergy Asthma Immunol 2007;98:57-63.
Ali AK. Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor. Ther Clin Risk Manag 2011;7:337-44.
Grant NN , Deeb ZE, Chia SH. Clinical experience with angiotensin-converting enzyme inhibitorinduced angioedema. Otolaryngol Head Neck Surg 2007;137:931–5.
Kostis JB, Packer M, Black HR et al. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am J Hypertens 2004;17:103–11.
Gabb GM, Ryan P, Wing LM et al. Epidemiological study of angioedema and ACE inhibitors. Aust N Z J Med 1996;26:777–82.
Hoover T, Lippmann M, Grouzmann E et al. Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors. Clin Exp Allergy 2010;40:50–61.
Korniyenko A, Alviar CL, Cordova JP et al. Visceral angioedema due to angiotensin-converting enzyme inhibitor therapy. Cleve Clin J Med. 2011 May;78(5):297-304.
Iwamoto K, Mihara S, Ikezawa Z, et al. [National prevalence survey of hereditary angioedema in Japan]. Arerugi 2011;60:26-32 (in Japanese).
Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf. 2001;24(8):599-606.
Zingale L, Beltrami L, Zanichelli A et al. Angioedema without urticaria: a large clinical survey. CMAJ 2006;175(9):1065-70.
Krikorian RK, Quick A, Tal A. Angioedema following the intravenous administration of metoprolol. Chest 1994; 106:1922-3.
Sauvi L, Gras-Champel V, Decocq G et al. [Angioedema associated with the use of dihydropyridines.]. Therapie 1999;54:64-5 (in French).
Burches E, Garcia-Verdegay F, Ferrer M et al. Amiodarone-induced angioedema. Allergy 2000;55:1199- 200.
Cooney C, Nagy A. Angio-oedema associated with risperidone. BMJ 1995;311:1204.
Kimyai-Asadi A, Harris JC, Nousari HC. Critical overview: adverse cutaneous reactions to psychotropic medications. J Clin Psychiatry 1996;60:714-25.
Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001;87:177-80.
Harada S, Horikawa T, Ashida M et al. Aspirin enhances the induction of type I allergic symptoms when combined with food and exercise in patients with food-dependent exercise-induced anaphylaxis. Br J Dermatol 2001;145: 336-9.
Doсa I, Blanca-Lуpez N, Jagemann LR et al. Response to a selective COX-2 inhibitor in patients with urticaria_angioedema induced by nonsteroidal anti-inflammatory drugs. Allergy 2011;66:1428-33.
Kim SH, Ye YM, Lee SK et al. Genetic mechanism of aspirin-induced urticaria_angioedema. Curr Opin Allergy Clin Immunol 2006;6:266-70.
Lerch M. Drug-induced angioedema. Chem Immunol Allergy 2012;97:98-105.
Stevenson DD, Simon RA. Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs. In: Middleton E, Reed CE, Ellis EF et al (eds). Allergy: Principles
Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol 2005;53:373-88.
Pacor ML, Di Lorenzo G, Corrocher R. Efficacy of leukotriene receptor antagonist in chronic urticaria. A doubleblind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and_or acetylsalicylic acid. Clin Exp Allergy 2001;31:1607-14.
Asero R. Clinical management of adult patients with a history of nonsteroidal anti-inflammatory drug-induced urticaria _angioedema: update. Allergy Asthma Clin Immunol 2007;3:24-30.
Matucci A, Parronchi P, Vultaggio A et al. Partial safety of the new COX-2 inhibitor rofecoxib in NSAIDs high sensitive patients. Allergy 2004;59:1133-4.
Weberschock TB, Muller SM, Boehncke S et al. Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature. Arch Dermatol Res 2007;299:169-75.
Sanchez-Borges M, Gonzalez-Aveledo LA. Angiotensinconverting enzyme inhibitors and angioedema. Allergy Asthma Immunol Res 2010;2:195-8.
Bork K, Fischer B, Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy. Am J Med 2003;114: 294-8.
Дерменджиев С. Тежка алергична патология при професионална експозиция на материали от военната промишленост. Алергии Хиперсензитивност Астма 2014, 11 (1):76-82.
Дерменджиев С, Делева П. Алергични реакции от субстанции с неизвестен физико-химичен състав. Bulgarian medicine 2013, 4: 46- 50.
Bouillet L, Longhurst H, Boccon-Gibod I et al. Disease expression in women with hereditary angioedema (PREHAEAT). Am J Obstet Gynecol 2008;199(484):e1-4.
Dunn CJ, Goa KL. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999 Jun;57(6):1005-32.
Дерменджиев С, Делева П, Пенчев Б. Наследственият ангиоедем – сериозен проблем за здравето при деца и млади пациенти. Medinfo 2014; 8 :56-59.
Chi C, Kulkarni A, Lee CA et al. The obstetric experience of women with factor XI deficiency. Acta Obstet Gynecol Scand 2009;88:1095-100.
Дерменджиев С, Симеонова Р. Рядко срещани алергични прояви при козметични манипулации. В: Трета национална конференция за редки болести – конферентен сборник, 2013: 125-126.
Manikkam M, Crespi EJ, Doop DD et al. Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology 2004;145:790-8.
Дерменджиев С. Кожно-лигавични алергични прояви при селскостопанските работници. Bulgarian medicine 2014, 3: 32- 36.
Sathishkumar K, Elkins R, Yallampali U et al. Elevated androgens levels during pregnancy impair fetal growth due to placental insufficiency and programs for adult hypertension in rats. Biol Reprod 2009;81:250.
Дерменджиев С. Алергия и хомеопатични лекарствени продукти – парадокс, възможен риск или нещо друго: клиничен случай. Алергии Хиперсензитивност Астма 2011, 8(1):40-54.
Czaller I, Visy B, Csuka D et al. The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey. Eur J Obstet Gynecol Reprod Biol 2010;152:44-9.
Дерменджиев С. Книжният прах – рисков фактор за сенсибилизация при професионално експонирани лица. В: Трета национална конференция за редки болести – конферентен сборник, 2013: 118-120.
Hardy F, Ngwingtin L, Bazin C, et al. Hereditary angioneurotic edema and pregnancy. J Gynecol Obstet Biol Reprod (Paris) 1990;19:65-8.
Firazyr (icatibant acetate). Berlin (Germany): Jerini AG; 2009.Kalbitor (ecallantide). Cambridge (MA): Dyax Corp; 2009.
Kalbitor (ecallantide). Cambridge (MA): Dyax Corp; 2009.
Мурджева М, Спасова М, Бошева М и съавт. Първични имунни дефицити – експертна дейност за диагностика и лечение в УМБАЛ „ Свети Георги“. В: Четвърта национална конференция за редки болести и лекарства сираци – конферентен сборник, 2013: 78.
Tranexamic acid (Lysteda) for treatment of menorrhagia. Med Lett Drugs Ther 2010;52:54-5.
Visy B, Fust G, Varga L et al. Sex hormones in hereditary angioneurotic oedema. Clin Endocrinol (Oxf) 2004;60:508 15.
Cyklokapron (Pharmacia). In: Krogh CME, editor. Compendium of pharmaceutical and specialties. 28th ed. Ottawa: Canadian Pharmaceutical Association; 1993: 311-2.
Campbell SJ, Mackie IJ, Robinson GE, et al. Contact factor mediated fibrinolysis is increased by the combined oral contraceptive pill. Br J Obstet Gynaecol 1993;100:79-84.
Pelissier C, Blacker C, Feinstein MC et al. Antiovulatory action of chlormadinone acetate. Contracept Fertil Sex (Paris) 1994;22:37-40.
Cimbollek S, Gonzalez-Quevedo T, Diaz M. To become or not become pregnant with hereditary angioedema. The 5th C1-INH DeficiencyWorkshop; May 31-June 2, 2007; Budapest, Hungary. Abstract book: 30.
McGlinchey PG, McCluskey DR. Hereditary angioedema precipitated by estrogen replacement therapy in a menopausal woman. Am J Med Sci 2000;320:212-3.
Madsen JS, Kristensen SR, Gram J et al. Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women. J Thromb Haemost 2003;1:1984-91.
Nelson HD. Menopause. Lancet 2008;371:760-70.
Fechner S, Husen B, Thole H et al. Expression and regulation of estrogen-converting enzymes in ectopic human endometrial tissue. Fertil Steril 2007;88(suppl 4):1029-38.
Rousset-Jablonski C, Thalabard JC, Gompel A. Tamoxifen contraindicated in women with hereditary angioedema? Ann Oncol 2009;20:1281-2.
Bellver J, Pellicer A. Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome. Fertil Steril 2009;92:1803-10.
Humaidan P, Quartarolo J, Papanikolaou EG. Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril 2010;94:389-400.
Caballero Т et al. Consensus Statement on the Diagnosis, Management, and Treatment of Angioedema Mediated by Bradykinin. Part II. Treatment, Follow-up, and Special Situations. J Investig Allergol Clin Immunol 2011; 21(6): 422-441.
Wilkin JK, Hammond JJ, Kirkendall WM. The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation. Arch Dermatol1980;116:902–5.
Slater EE , Merrill DD, Guess HA et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 1988;260:967–70.
Sigler C, Annis K, Cooper K, Haber H, Van deCarr S. Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor. Arch Dermatol. 1997 Aug;133(8):972-5.
Banerji A, Clark S, Blanda M, et al. Multicenter study of patients with angiotensin-converting enzyme inhibitorinduced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 2008;100:327–32.
Blais C Jr, Rouleau JL, Brown NJ et al. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin converting enzyme inhibitor-associated angioedema. Immunopharmacology 1999;43:293-302.
Duan QL, Nikpoor B, Dube MP et al. A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors. Am J Hum Genet 2005;77:617-26.
Sprinkle TJ, Stone AA, Venema RC et al. Assignment of the membrane-bound human aminopeptidase P gene (XPNPEP2) to chromosome Xq25. Genomics 1998;50:114-6.
Bas M, Hoffmann TK, Kojda G. Evaluation and management of angioedema of the head and neck. Curr Opin Otolaryngol Head Neck Surg 2006;14:170-5.
ONTARGET Investigators, Yusuf S, Teo KK et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008;358:1547-59.
Malde B, Regalado J, Greenberger PA. Investigation of angioedema associated with the use of angiotensinconverting enzyme inhibitors and angiotensin receptor blockers. Ann Allergy Asthma Immunol 2007;98:57-63.
Ali AK. Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor. Ther Clin Risk Manag 2011;7:337-44.
Grant NN , Deeb ZE, Chia SH. Clinical experience with angiotensin-converting enzyme inhibitorinduced angioedema. Otolaryngol Head Neck Surg 2007;137:931–5.
Kostis JB, Packer M, Black HR et al. Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial. Am J Hypertens 2004;17:103–11.
Gabb GM, Ryan P, Wing LM et al. Epidemiological study of angioedema and ACE inhibitors. Aust N Z J Med 1996;26:777–82.
Hoover T, Lippmann M, Grouzmann E et al. Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors. Clin Exp Allergy 2010;40:50–61.
Korniyenko A, Alviar CL, Cordova JP et al. Visceral angioedema due to angiotensin-converting enzyme inhibitor therapy. Cleve Clin J Med. 2011 May;78(5):297-304.
Iwamoto K, Mihara S, Ikezawa Z, et al. [National prevalence survey of hereditary angioedema in Japan]. Arerugi 2011;60:26-32 (in Japanese).
Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf. 2001;24(8):599-606.
Zingale L, Beltrami L, Zanichelli A et al. Angioedema without urticaria: a large clinical survey. CMAJ 2006;175(9):1065-70.
Krikorian RK, Quick A, Tal A. Angioedema following the intravenous administration of metoprolol. Chest 1994; 106:1922-3.
Sauvi L, Gras-Champel V, Decocq G et al. [Angioedema associated with the use of dihydropyridines.]. Therapie 1999;54:64-5 (in French).
Burches E, Garcia-Verdegay F, Ferrer M et al. Amiodarone-induced angioedema. Allergy 2000;55:1199- 200.
Cooney C, Nagy A. Angio-oedema associated with risperidone. BMJ 1995;311:1204.
Kimyai-Asadi A, Harris JC, Nousari HC. Critical overview: adverse cutaneous reactions to psychotropic medications. J Clin Psychiatry 1996;60:714-25.
Stevenson DD, Sanchez-Borges M, Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001;87:177-80.
Harada S, Horikawa T, Ashida M et al. Aspirin enhances the induction of type I allergic symptoms when combined with food and exercise in patients with food-dependent exercise-induced anaphylaxis. Br J Dermatol 2001;145: 336-9.
Doсa I, Blanca-Lуpez N, Jagemann LR et al. Response to a selective COX-2 inhibitor in patients with urticaria_angioedema induced by nonsteroidal anti-inflammatory drugs. Allergy 2011;66:1428-33.
Kim SH, Ye YM, Lee SK et al. Genetic mechanism of aspirin-induced urticaria_angioedema. Curr Opin Allergy Clin Immunol 2006;6:266-70.
Lerch M. Drug-induced angioedema. Chem Immunol Allergy 2012;97:98-105.
Stevenson DD, Simon RA. Sensitivity to aspirin and nonsteroidal anti-inflammatory drugs. In: Middleton E, Reed CE, Ellis EF et al (eds). Allergy: Principles
Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol 2005;53:373-88.
Pacor ML, Di Lorenzo G, Corrocher R. Efficacy of leukotriene receptor antagonist in chronic urticaria. A doubleblind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and_or acetylsalicylic acid. Clin Exp Allergy 2001;31:1607-14.
Asero R. Clinical management of adult patients with a history of nonsteroidal anti-inflammatory drug-induced urticaria _angioedema: update. Allergy Asthma Clin Immunol 2007;3:24-30.
Matucci A, Parronchi P, Vultaggio A et al. Partial safety of the new COX-2 inhibitor rofecoxib in NSAIDs high sensitive patients. Allergy 2004;59:1133-4.
Weberschock TB, Muller SM, Boehncke S et al. Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature. Arch Dermatol Res 2007;299:169-75.
Published
2015-09-15
How to Cite
1.
Дерменджиев С, Тодорова А, Дерменджиев Т, Делева П, Симеонова Р. Особености в протичането, диагностиката и лечението на медикаментозно индуцирания ангиоедем и на ангиоедема при жени. Редки болести и лекарства сираци [Internet]. 2015Sep.15 [cited 2024Nov.23];6(1):3-11. Available from: https://journal.raredis.org/index.php/RBLS/article/view/1
Issue
Section
Статии
Съдържанието е достъпно под лиценза Creative Commons Attribution-NonCommercial 4.0 International License.
